欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  JAK/STAT Signaling  /  JAK  /  枸橼酸托法替尼

CAS No.: 540737-29-9

枸橼酸托法替尼 Catalog No. CSN12901

Synonyms: Tasocitinib citrate;CP-690550 citrate;Tofacitinib (citrate)

Tofacitinib Citrate is a FDA-approved JAK inhbitor used to treat moderate to severe rheumatoid arthritis, with IC50 values of 1 nM, 20 nM and 112 nM for JAK3, JAK2 and JAK1, respectively.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 靶点JAK1

    IC50:112nM
    JAK2

    IC50:20nM
    JAK3

    IC50:1nM
    Lck

    IC50:3,870nM
    ROCK2

    IC50:3,400nM
  • 描述
  • 细胞研究
  • Cell Data
  • 更多
  • 动物研究
    剂量

    Rat: 5 mg/kg - 50 mg/kg[3] (i.v.), 10 mg/kg - 100 mg/kg[4] (p.o.) Mice: 1 mg/kg - 100 mg/kg[5] (p.o.)

    给药途径

    i.v., p.o.

  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT01023100Arthritis, RheumatoidPhase 1Completed-United States, Massachusetts ... more >> Pfizer Investigational Site Woburn, Massachusetts, United States, 01801 Collapse <<
    NCT01185184HealthyPhase 1Completed-Singapore ... more >> Pfizer Investigational Site Singapore, Singapore, 188770 Collapse <<
    NCT01246583PsoriasisPhase 2Completed-United States, Alabama ... more >> Pfizer Investigational Site Mobile, Alabama, United States, 36606 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90045 United States, Florida Pfizer Investigational Site Orange Park, Florida, United States, 32073 United States, Nebraska Pfizer Investigational Site Omaha, Nebraska, United States, 68144 United States, New Mexico Pfizer Investigational Site Albuquerque, New Mexico, United States, 87106 United States, South Dakota Pfizer Investigational Site Rapid City, South Dakota, United States, 57702 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75231 Canada, Ontario Pfizer Investigational Site Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2K 4L5 Pfizer Investigational Site Montreal, Quebec, Canada, H3Z 2S6 Canada Pfizer Investigational Site Quebec, Canada, G1V 4X7 Collapse <<
  • 更多
  • 参考文献

实验方案

技术信息

CAS号 540737-29-9 储存条件
分子式 C22H28N6O8 运输 蓝冰
分子量 504.49 别名 Tasocitinib citrate;CP-690550 citrate;Tofacitinib (citrate);CP 690,550;CP-690550;CP-690550-10;CP-690,550-10;Tofacitinib;tasocitinib. Trade name Xeljanz;枸橼酸托法替尼
溶解度
DMSO100.0 mg/mL (198.2 mM) warming
Waterinsoluble
动物实验配方
IP2% DMSO+water2 mg/mLclear
PO0.5% CMC-Na80 mg/mLsuspension

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们